Your browser doesn't support javascript.
loading
Retroperitoneal fibrosis and ß-blocking agents: Is there an association?
Kharagjitsing, Hardjit; van Eekeren, Rike; van Puijenbroek, Eugène P; van Gelder, Teun; van Bommel, Eric F H.
Afiliação
  • Kharagjitsing H; Department of Internal medicine, Dutch national center of expertise for retroperitoneal fibrosis, Albert Schweitzer hospital, Dordrecht, The Netherlands.
  • van Eekeren R; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Puijenbroek EP; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
  • van Gelder T; Department of Pharmacotherapy, epidemiology and economics, Groningen Research Institute of Pharmacy, University of Groningen, The Netherlands.
  • van Bommel EFH; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Br J Clin Pharmacol ; 87(7): 2891-2901, 2021 07.
Article em En | MEDLINE | ID: mdl-33326117

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Retroperitoneal Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Retroperitoneal Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article